The Montreal-based company is at risk from potential tariffs from President Donald Trump and Canada’s government that could adversely affect its financial results.
Purdue’s Young Institute Pharmaceutical Manufacturing Consortium is working to address bottlenecks in efficiency, contamination control, and regulatory compliance.
Aragen Life Sciences stands to benefit as the biopharma industry looks to derisk its supply chains and shift outsourcing away from China to Indian service providers.
President Trump in an address to a joint session of Congress said the European Union and India, among other nations, charge “tremendously higher” tariffs on U.S. goods.
The company’s experience as a former RNA drug developer gives it a unique edge — it understands not just how to make RNA, but how to make it work in real-world applications.
With a portfolio that spans first-in-human trials to commercial production, KBI is a solutions provider whose specialty is tackling the toughest molecules.
The first commercial scale “smart” factory is in New Jersey, with other integrated development and manufacturing organization facilities being built in Belgium and Japan.
Plant 5 will be operational in April and the CDMO is moving forward with plans for the construction of Plant 6 to “maintain the world’s No. 1 manufacturing capacity.”
CEO Greg Behar said recent investments and partnerships have significantly expanded the global CDMO’s capacity in key areas such as pre-filled syringes and lyophilization.
Part of Vetter’s Center for Visual Inspection and Logistics, construction of the 22,500-square-meter extension began in late 2024, with completion expected by 2028.
The investment supports the construction of an R&D and manufacturing hub to advance Entos’ Fusogenix PLV drug delivery platform and expand Canadian biomanufacturing capacity.
Pharmaceutical manufacturing operates in a high-stakes environment where regulatory compliance, product integrity, and operational uptime are non-negotiable. As the industry becomes...
Discover the latest contract manufacturing key trends for the life science industry, including compliance, digital transformation and more. Don't let your organization fall behind...
As the life sciences sector evolves with personalized medicine, biologics, and digitalization, manufacturers must innovate, invest in advanced tech, and adopt agile manufacturing...
